RAPT Therapeutics Inc.
RAPT | NASDAQ
$58.01
$0 (+0.01%)
At close: Mar 6, 2026, 9:30 AM ET
Market Data
Market Cap $1.61B
Enterprise Value $1.45B
Beta 0.44
Average Volume 2.45M
Shares Outstanding (Diluted) 26.96M
Shares Change YoY 454.46%
Institutional Ownership 50.55%
Exchange NASDAQ
ISIN US75382E2081
Price Performance
Price Change 1M 0.2%
Price Change 3M 63.9%
Price Change 6M 142.2%
Price Change YTD 82.1%
Price Change 1Y 373.9%
Price Change 3Y -58.5%
Price Change 5Y -66.8%
1M CAGR (ann.) 0.6%
1Y CAGR (ann.) 541.7%
5Y CAGR (ann.) -17.3%
All-Time CAGR -8.8%
Valuation
PE Ratio -5.24
Forward PE N/A
PEG Ratio -0.45
Forward PEG -1.77
PS Ratio N/A
Forward PS 1,995.90
PB Ratio 10.58
P/FCF Ratio -18.55
P/Adj. FCF Ratio -15.24
P/OCF Ratio -20.57
EV/Sales N/A
EV/EBIT -13.33
EV/EBITDA -13.45
EV/FCF -16.76
Earnings Yield -19.1%
FCF Yield -5.4%
Adj. FCF Yield -6.6%
Financial Health
Net Cash $154.75M
Total Debt $2.6M
Cash & Short-Term Investments $157.34M
Total Assets $165.74M
Current Ratio 12.04
Quick Ratio 12.04
Debt / Equity Ratio 0.02
Debt / EBITDA -0.02
Debt / FCF -0.03
OCF / Debt -33.35
Interest Coverage 0.00
Altman Z-Score 63.34
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -21.7%
Returns
Return on Assets -31.6%
Return on Equity -31.8%
Return on Invested Capital -37.6%
Return on Capital Employed -38.2%
Return on Tangible Assets -31.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -150.0%
Revenue CAGR 5Y -82.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 31.9%
EPS CAGR 5Y 7.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y 3.5%
FCF CAGR 5Y -11.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 15
EPS Growth Next 3Y 13.8%
Revenue Growth Next 3Y N/A
Earnings Date Mar 4, 2026
EPS Estimate (next Q) -$0.82
EPS Growth Est (next Q) -91.0%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $44.60
Price Target Upside -23.1%
Cash Flow
Operating Cash Flow $-86.58M
Free Cash Flow $-86.66M
Adj. Free Cash Flow $-105.47M
FCF Per Share -$2.83
OCF Per Share -$2.82
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-200K
Operating Income $-112.64M
EBITDA $-108.01M
Net Income $-105.64M
EPS (Diluted) -$11.07
Revenue / Employee N/A
Profit / Employee $-1.58M
Employees 67
Add to Watchlist
Select watchlists to add or remove RAPT